JESSICA BJERK: Open Payments
NPI 1639452931 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 13 payments from 8 companies in 2025. Trend: 2023 $8,530 · 2024 $2,791 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $80 |
| Alnylam Pharmaceuticals Inc. | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Lilly USA, LLC | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Chiesi USA, Inc. | 1 | $15 |
Products named: WAINUA, ONPATTRO, VERQUVO, CAMZYOS, ZEPBOUND, ELIQUIS, FUROSCIX, KENGREAL.
Industry payments across TX — which companies pay providers there.
